RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the ...

PranaX Corporation, a pioneer in exosome-based regenerative wellness, has appointed Phillip Maderia as its new Chief ...

PranaX, a Houston, USA-based biotech specializing in exosome-based regenerative therapies, has appointed Phillip Maderia as ...

Say goodbye to hair loss with exosome therapy Explore how exosomes work to stimulate hair follicles and enhance hair density ...

While the trial focuses on stem cell transplantation, it hints at broader mechanisms—like exosome release—that could transform Parkinson's care by repairing brain damage and enhancing dopamine ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Exosome Research Market worth ...

Temporomandibular joint osteoarthritis (TMJOA) is a debilitating condition that causes severe joint pain, restricted mobility ...

An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

The TSXV serves as a vital platform for early-stage, high-growth companies, providing access to capital and a strong investor network. In 2024, 80% of the TSXV Venture 50™ companies operated ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases.